You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (10)

Journals (0)

1-10 of 10 results for glycoengineered

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: A new glycoengineered form of anti-CD20 monoclonal antibody in treatment of multiple sclerosis

Open access

Review article

First published 2026

A new glycoengineered form of anti-CD20 monoclonal antibody in treatment of multiple sclerosis

Krzysztof Selmaj, Ralf Gold, Igor Selmaj [...]

Therapeutic Advances in Neurological Disorders

Select article: Customized Glycoengineering in Plant-Based Expression Systems

Retricted access

Research article

First published 2021-1

Customized Glycoengineering in Plant-Based Expression Systems

Sylvain Marcel

Genetic Engineering & Biotechnology News

Select article: A phase 2 multicenter study of ublituximab,a novel glycoengineered anti-CD20 monoclonal antibody,in patients with relapsing forms of multiple sclerosis

Open access

Research article

First published 2021-3

A phase 2 multicenter study of ublituximab,a novel glycoengineered anti-CD20 monoclonal antibody,in patients with relapsing forms of multiple sclerosis

Edward Fox, Amy E Lovett-Racke, Matthew Gormley [...]

Multiple Sclerosis Journal

Select article: Hypersensitivity Reactions to Obinutuzumab in Cynomolgus Monkeys and Relevance to Humans

Free access

Research article

First published 2017-7

Hypersensitivity Reactions to Obinutuzumab in Cynomolgus Monkeys and Relevance to Humans

Elisabeth Husar, Maria Solonets, Olaf Kuhlmann [...]

Toxicologic Pathology

Select article: Obinutuzumab for relapsed or refractory indolent non-Hodgkin’s lymphomas

Free access

Review article

First published 2016-4

Obinutuzumab for relapsed or refractory indolent non-Hodgkin’s lymphomas

Ludovic Gabellier, Guillaume Cartron

Therapeutic Advances in Hematology

Select article: Obinutuzumab for chronic lymphocytic leukemia: promise of the first treatment approved with breakthrough therapy designation

Retricted access

Review article

First published 2015-10

Obinutuzumab for chronic lymphocytic leukemia: promise of the first treatment approved with breakthrough therapy designation

Ashish Kumar Kakkar, Sadasivam Balakrishnan

Journal of Oncology Pharmacy Practice

Select article: Role of N -Glycosylation in Gastrointestinal Cancers

Retricted access

Review article

First published 2024-12

Role of N -Glycosylation in Gastrointestinal Cancers

Ruirui Xu, Lois Balmer, Gengzhen Chen [...]

OMICS: A Journal of Integrative Biology

Select article: Development of a Hyperglycosylated IFN Alfacon-1 (CIFN): Toward Bimonthly or Monthly Dosing for Antiviral Therapies

Retricted access

Research article

First published 2015-08

Development of a Hyperglycosylated IFN Alfacon-1 (CIFN): Toward Bimonthly or Monthly Dosing for Antiviral Therapies

Joshua S. Taylor, Qingling Zhang, Justin G. Julander [...]

Journal of Interferon & Cytokine Research

Select article: Obinutuzumab

Retricted access

Review article

First published 2014-10

Obinutuzumab

Arpita Shah

Annals of Pharmacotherapy

Select article: Immunoglobulin G and Aging: Biological Functions and Its Crosstalk with the Gut Microbiota

Retricted access

Review article

First published 2026-4

Immunoglobulin G and Aging: Biological Functions and Its Crosstalk with the Gut Microbiota

Xin-yi Zhang, De-guan Li

Rejuvenation Research

1
10 / page

Article type

Publication date

Subjects

Access